Anesth Analg 2004;99:1440-1444
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000134805.30532.59
TECHNOLOGY, COMPUTING, AND SIMULATION
Electron Microscopic Evaluations of Clot Morphology During Thrombelastography®
Jun Kawasaki, MD*,
Nobuyuki Katori, MD ,
Mitsuharu Kodaka, MD*,
Hideki Miyao, MD*, and
Kenichi A. Tanaka, MD
*Department of Anesthesiology, Saitama Medical Center, Saitama Medical School, Saitama, Japan, and the
Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia.
Address correspondence and reprint requests to Jun Kawasaki, MD, Department of Anesthesiology, Saitama Medical Center, 1981 Kamoda, Kawagoe-Shi, Saitama, Japan. Address email tojkawasak{at}saitama-med.ac.jp
In this study, we characterized clot morphology with a scanning electron microscope (SEM) at time points corresponding to the commonly used thrombelastography (TEG®) variables, illustrating the correlation of the physical clot formation with TEG® tracings. The first channel of the TEG® analyzer was used to obtain the tracings of clot formation, while the sub-samples for the SEM were obtained from the second TEG® channel. Different types of samples were examined, including whole blood, abciximab-treated whole blood, platelet-rich plasma (PRP), and abciximab-treated PRP. The SEM images were obtained at reaction time, different amplitudes (530 mm), maximum amplitude (MA), and at amplitude 60 min after MA. In the whole blood, coarse fibrin and activated platelets were observed at reaction time and fibrin strands progressively became more solid and intertwined at amplitude 10 mm and thereafter. Red blood cells were surrounded with fibrin strands at amplitude 30 mm and were tightly packed by fibrin strands at MA. In abciximab-treated whole blood, red blood cell shape was maintained at MA. The process of fibrin formation and platelet activation was also examined in PRP. Abciximab did not block platelet shape change, although the blockage of fibrin binding to platelets was shown on the TEG® analyzer. In summary, we have shown structural changes of the forming clot in relation to TEG® variables.
IMPLICATIONS: We have shown structural changes of the forming clot in relation to thrombelastography variables using scanning electron microscopy. Clot structure was examined in the whole blood and platelet-rich plasma in the presence and the absence of abciximab.
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Tanaka, F. Szlam, H. Y. Sun, T. Taketomi, and J. H. Levy
Thrombin Generation Assay and Viscoelastic Coagulation Monitors Demonstrate Differences in the Mode of Thrombin Inhibition Between Unfractionated Heparin and Bivalirudin
Anesth. Analg.,
October 1, 2007;
105(4):
933 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Bliden, J. DiChiara, U. S. Tantry, A. K. Bassi, S. K. Chaganti, and P. A. Gurbel
Increased Risk in Patients With High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention: Is the Current Antiplatelet Therapy Adequate?
J. Am. Coll. Cardiol.,
February 13, 2007;
49(6):
657 - 666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Gurbel, K. P. Bliden, K. Guyer, P. W. Cho, K. A. Zaman, R. P. Kreutz, A. K. Bassi, and U. S. Tantry
Platelet Reactivity in Patients and Recurrent Events Post-Stenting: Results of the PREPARE POST-STENTING Study
J. Am. Coll. Cardiol.,
November 15, 2005;
46(10):
1820 - 1826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Manchio, J. Gu, L. Romar, J. Brown, J. Gammie, R. N. Pierson III, B. Griffith, and R. S. Poston
Disruption of Graft Endothelium Correlates With Early Failure After Off-Pump Coronary Artery Bypass Surgery
Ann. Thorac. Surg.,
June 1, 2005;
79(6):
1991 - 1998.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|